Found: 10
Select item for more details and to access through your institution.
Acceptable changes in quality attributes of glycosylated biopharmaceuticals.
- Published in:
- 2011
- By:
- Publication type:
- Letter
The Path Towards a Tailored Clinical Biosimilar Development.
- Published in:
- BioDrugs, 2020, v. 34, n. 3, p. 297, doi. 10.1007/s40259-020-00422-1
- By:
- Publication type:
- Article
Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained.
- Published in:
- BioDrugs, 2018, v. 32, n. 2, p. 129, doi. 10.1007/s40259-018-0262-9
- By:
- Publication type:
- Article
The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 2, p. 269, doi. 10.1177/1078155217731506
- By:
- Publication type:
- Article
Similarity assessment of quality attributes of biological medicines: the calculation of operating characteristics to compare different statistical approaches.
- Published in:
- AAPS Open, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s41120-019-0033-9
- By:
- Publication type:
- Article
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 1509, doi. 10.2147/DDDT.S130318
- By:
- Publication type:
- Article
The Assessment of Quality Attributes for Biosimilars: a Statistical Perspective on Current Practice and a Proposal.
- Published in:
- AAPS Journal, 2019, v. 21, n. 1, p. 1, doi. 10.1208/s12248-018-0275-9
- By:
- Publication type:
- Article
Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience?
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 6, p. 481, doi. 10.1007/s40261-018-0637-1
- By:
- Publication type:
- Article
Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 495, doi. 10.1007/s40259-013-0036-3
- By:
- Publication type:
- Article